139 related articles for article (PubMed ID: 8269201)
1. The in-vitro effect of antineoplastic agents on proliferative activity and cytoskeletal components of plaque-derived smooth-muscle cells from human coronary arteries.
Voisard R; Dartsch PC; Seitzer U; Hannekum A; Roth D; Kochs M; Hombach V
Coron Artery Dis; 1993 Oct; 4(10):935-42. PubMed ID: 8269201
[TBL] [Abstract][Full Text] [Related]
2. A prescreening system for potential antiproliferative agents: implications for local treatment strategies of postangioplasty restenosis.
Voisard R; Seitzer U; Baur R; Dartsch PC; Osterhues H; Höher M; Hombach V
Int J Cardiol; 1995 Aug; 51(1):15-28. PubMed ID: 8522393
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroid agents inhibit proliferation of smooth muscle cells from human atherosclerotic arteries in vitro.
Voisard R; Seitzer U; Baur R; Dartsch PC; Osterhues H; Höher M; Hombach V
Int J Cardiol; 1994 Mar; 43(3):257-67. PubMed ID: 8181884
[TBL] [Abstract][Full Text] [Related]
4. High-dose diltiazem prevents migration and proliferation of vascular smooth muscle cells in various in-vitro models of human coronary restenosis.
Voisard R; Koschnick S; Baur R; Vogel U; Mattfeldt T; Hemmer W; Hannekum A; Höher M; Hombach V
Coron Artery Dis; 1997; 8(3-4):189-201. PubMed ID: 9237030
[TBL] [Abstract][Full Text] [Related]
5. [In vitro balloon treatment of coronary plaque material of the human: effect of dilation time on proliferation of smooth muscle cells].
Voisard R; Dartsch PC; Seitzer U; Grupp C; Hannekum A; Kochs M; Hombach V
Vasa Suppl; 1991; 33():138-9. PubMed ID: 1788646
[TBL] [Abstract][Full Text] [Related]
6. Effect of antineoplastic agents on smooth muscle cell proliferation in vitro: implications for prevention of restenosis after transluminal angioplasty.
Cragg AH; Stoll LL; Smith TP; Berbaum K
J Vasc Interv Radiol; 1992 May; 3(2):273-7. PubMed ID: 1385739
[TBL] [Abstract][Full Text] [Related]
7. The paradigm of restenosis following percutaneous transluminal coronary angioplasty.
Preisack MB; Karsch KR
Eur Heart J; 1993 Nov; 14 Suppl I():187-92. PubMed ID: 8293774
[TBL] [Abstract][Full Text] [Related]
8. In vitro growth characteristics of human atherosclerotic plaque cells: comparison of cells from primary stenosing and restenosing lesions of peripheral and coronary arteries.
Dartsch PC; Voisard R; Betz E
Res Exp Med (Berl); 1990; 190(2):77-87. PubMed ID: 2349398
[TBL] [Abstract][Full Text] [Related]
9. Smooth muscle cell de-differentiation is a fundamental change preceding wound healing after percutaneous transluminal coronary angioplasty in humans.
Ueda M; Becker AE; Naruko T; Kojima A
Coron Artery Dis; 1995 Jan; 6(1):71-81. PubMed ID: 7767506
[TBL] [Abstract][Full Text] [Related]
10. Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions.
MacLeod DC; Strauss BH; de Jong M; Escaned J; Umans VA; van Suylen RJ; Verkerk A; de Feyter PJ; Serruys PW
J Am Coll Cardiol; 1994 Jan; 23(1):59-65. PubMed ID: 8277096
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic roles of heparin and glucocorticoids to prevent restenosis after coronary angioplasty.
Berk BC; Gordon JB; Alexander RW
J Am Coll Cardiol; 1991 May; 17(6 Suppl B):111B-117B. PubMed ID: 2016469
[TBL] [Abstract][Full Text] [Related]
12. [Effect of dihematoporphyrin derivatives on cultivated human smooth muscle cells from normal and atherosclerotic vascular segments-- Overview of results and implications for photodynamic therapy].
Dartsch PC; Betz E; Ischinger T
Z Kardiol; 1991 Jan; 80(1):6-14. PubMed ID: 1827935
[TBL] [Abstract][Full Text] [Related]
13. Growth characteristics and cytoskeletal organization of cultured smooth muscle cells from human primary stenosing and restenosing lesions.
Dartsch PC; Voisard R; Bauriedel G; Höfling B; Betz E
Arteriosclerosis; 1990; 10(1):62-75. PubMed ID: 2404491
[TBL] [Abstract][Full Text] [Related]
14. Redifferentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression.
Aikawa M; Sakomura Y; Ueda M; Kimura K; Manabe I; Ishiwata S; Komiyama N; Yamaguchi H; Yazaki Y; Nagai R
Circulation; 1997 Jul; 96(1):82-90. PubMed ID: 9236421
[TBL] [Abstract][Full Text] [Related]
15. The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes?
Lafont A; Libby P
J Am Coll Cardiol; 1998 Jul; 32(1):283-5. PubMed ID: 9669282
[TBL] [Abstract][Full Text] [Related]
16. Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation.
Bonta PI; Pols TW; van Tiel CM; Vos M; Arkenbout EK; Rohlena J; Koch KT; de Maat MP; Tanck MW; de Winter RJ; Pannekoek H; Biessen EA; Bot I; de Vries CJ
Circulation; 2010 May; 121(18):2023-32. PubMed ID: 20421523
[TBL] [Abstract][Full Text] [Related]
17. Increased endothelin release by cultured human smooth muscle cells from atherosclerotic coronary arteries.
Haug C; Voisard R; Lenich A; Baur R; Höher M; Osterhues H; Hannekum A; Vogel U; Mattfeldt T; Hombach V; Grünert A
Cardiovasc Res; 1996 May; 31(5):807-13. PubMed ID: 8763411
[TBL] [Abstract][Full Text] [Related]
18. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis.
Lanza GM; Yu X; Winter PM; Abendschein DR; Karukstis KK; Scott MJ; Chinen LK; Fuhrhop RW; Scherrer DE; Wickline SA
Circulation; 2002 Nov; 106(22):2842-7. PubMed ID: 12451012
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of smooth muscle cell proliferation after local drug delivery of the antimitotic drug paclitaxel using a porous balloon catheter.
Oberhoff M; Kunert W; Herdeg C; Küttner A; Kranzhöfer A; Horch B; Baumbach A; Karsch KR
Basic Res Cardiol; 2001; 96(3):275-82. PubMed ID: 11403421
[TBL] [Abstract][Full Text] [Related]
20. [Hormone therapy as a therapeutic option in prevention of restenosis after angioplasty? Analysis of estrogen and progesterone receptors in human coronary plaque cells in vitro].
Voisard R; Seitzer U; Hannekum A; Kochs M; Hombach V; Böhm W
Vasa Suppl; 1992; 35():130-1. PubMed ID: 1481016
[No Abstract] [Full Text] [Related]
[Next] [New Search]
